Dementia due to use of sedatives, hypnotics or anxiolytics
Dementia due to use of sedatives, hypnotics or anxiolytics is characterized by the development of persistent cognitive impairments (e.g., memory problems, language impairment, and an inability to perform complex motor tasks) that meet the definitional requirements of Dementia that are judged to be a direct consequence of sedative, hypnotic, or anxiolytic use and that persist beyond the usual duration of action or withdrawal syndrome associated with the substance. The amount and duration of sedative, hypnotic, or anxiolytic use must be sufficient to produce the cognitive impairment. The cognitive impairment is not better accounted for by a disorder that is not induced by sedatives, hypnotics, or anxiolytics such as a dementia due to another medical condition.
Differential diagnosis
When diagnosing Dementia due to use of sedatives, hypnotics or anxiolytics, the following ICD-11 disorders should be considered in the differential diagnosis:
Frequently asked questions
What disorders are in the differential diagnosis of Dementia due to use of sedatives, hypnotics or anxiolytics?
The differential diagnosis of Dementia due to use of sedatives, hypnotics or anxiolytics (6D84.1) includes: Otępienie spowodowane narażeniem na metale ciężkie i inne toksyny (6D85.2).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6D84.1 – WHO ICD-11
Open in interactive browser →